These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22792)

  • 21. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
    Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
    Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of regulating monoamine oxidase activity in different brain regions].
    Petrenko SV; Balakleevskiĭ AI
    Vopr Med Khim; 1980; 26(2):264-70. PubMed ID: 7456358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.
    Beliaev A; Learmonth DA; Soares-da-Silva P
    J Med Chem; 2006 Feb; 49(3):1191-7. PubMed ID: 16451083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    Henderson MG; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1993 Oct; 267(1):417-24. PubMed ID: 8229770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of alpha, alpha1-dipyridyl on noradrenaline, dopamine and 5-hydroxytryptamine levels and on dopamine-beta-hydroxylase activity in brain.
    Mogilnicka E; Szmigielski A; Niewiadomska A
    Pol J Pharmacol Pharm; 1975; 27(6):619-24. PubMed ID: 1715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence on turnover and level of hypothalamic noradrenaline by a new antihypertensive agent (GYKI 11679).
    Huszti Z; Szilágyi G; Mátyus P; Kasztreiner E
    J Neurochem; 1981 Nov; 37(5):1272-81. PubMed ID: 6117605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 31. Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.
    Amit Z; Brown ZW; Levitan DE; Ogren SO
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):65-75. PubMed ID: 603310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pyrazole, 4-methylpyrazole, 4-bromopyrazole and 4-iodopyrazole on brain noradrenaline levels of mice and rats.
    MacDonald E
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):513-24. PubMed ID: 990035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT; Angers M; Duhaime J; Kuchel O
    J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
    Dolphin A; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine-beta-hydroxylase inhibition acutely stimulates rats hypothalamic noradrenaline and dopamine neuronal activity as assessed from metabolic ratios and circulating glucose and ACTH responses.
    Smythe GA; Bradshaw JE; Gleeson RM; Nicholson MV
    Life Sci; 1985 Sep; 37(9):841-7. PubMed ID: 2993777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolinic acid: effects on brain catecholamine and c-AMP content during L-dopa and reserpine administration.
    Beskid M; Finkiewicz-Murawiejska L
    Exp Toxicol Pathol; 1992 Apr; 44(2):66-9. PubMed ID: 1319782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of voluntary ingestion of morphine by inhibition of dopamine-beta-hydroxylase.
    Brown ZW; Amit Z; Sinyor D; Rockman GE; Ogren SO
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):102-10. PubMed ID: 666451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I; Ross SB
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.